Latest Corline Biomedical News & Updates

See the latest news and media coverage for Corline Biomedical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Corline Biomedical

Antithrombotic and antiinflammatory surface coating solutions provider

corline.se
Founded year
1991
Company type
Public company
Number of employees
15–50

Last updated

Latest news about Corline Biomedical

In short: Corline Biomedical expanded its presence in the U.S. market through a landmark 10-year deal and FDA approval for its CHS technology.

Company announcements

  • Corline Biomedical

    Corline Biomedical publishes interim report for Q1 2026

    Net sales increased to 4,291 KSEK. The result after financial net was -2,501 KSEK. Issue and loan from Kardium provided 18.5 MSEK.

  • Corline Biomedical

    Corline Biomedical publishes annual report for 2025

    The annual report for the accounting year 2025 is made available on the company's website www.corline.se.

  • Corline Biomedical

    Corline Biomedical calls for annual general meeting

    The annual general meeting is held on 12 May 2026 in Uppsala with proposals regarding board election, fees and share issue authorization.

  • Corline Biomedical

    Corline Biomedical publishes year-end report for 2025

    Net sales amounted to 7,651 KSEK. Result after financial items was -14,714 KSEK. Product CHS™ is used in commercial launch in the USA.

Unlock all announcements with a

Media coverage

  • Morningstar

    Corline Biomedical AB

    Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company...

  • Reuters

    Corline Biomedical Q3 pre-tax loss widens to SEK 1.3 mln

    U.S. President Donald Trump is injecting nearly $9 billion into Intel in exchange for a 9.9% equity stake. But the money - which the struggling...

  • Reuters

    Corline Biomedical is applying for assessing Cytoparin as drug in upcoming clinical study

    Asian stock markets fought to hold their footing on Tuesday after a furious flight from U.S. assets undermined Wall Street and the dollar, while concerns...

Unlock all articles with a

Never miss news about Corline Biomedical

Track Corline Biomedical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.